Description of the study population
| . | PY of follow-up . | No. of cases . | Incidence per 1000 PYs . |
|---|---|---|---|
| All | 286 806 | 187 | 0.65 |
| Age, y | |||
| 15-34 | 109 840 | 64 | 0.58 |
| 35-49 | 137 154 | 105 | 0.77 |
| ≥ 50 | 39 813 | 18 | 0.45 |
| Sex and exposure group | |||
| MSM | 96 367 | 90 | 0.93 |
| IDU | 38 678 | 25 | 0.65 |
| Other men | 73 072 | 55 | 0.75 |
| Other women | 78 690 | 17 | 0.22 |
| Migration from sub-Saharan Africa | |||
| No | 250,578 | 177 | 0.71 |
| Yes | 36 229 | 10 | 0.28 |
| Calendar period | |||
| <1996 | 35 477 | 28 | 0.79 |
| 1996-1999 | 59 630 | 36 | 0.60 |
| 2000-2007 | 191 699 | 123 | 0.64 |
| CD4 cell count | |||
| Unknown | 4999 | 8 | 1.60 |
| 0-49 | 11 896 | 16 | 1.34 |
| 50-99 | 8141 | 19 | 2.33 |
| 100-199 | 22 939 | 34 | 1.48 |
| 200-349 | 55 832 | 51 | 0.91 |
| 350-499 | 66 301 | 32 | 0.48 |
| ≥ 500 | 116 698 | 27 | 0.23 |
| AIDS | |||
| No | 239 405 | 139 | 0.58 |
| Yes | 47 401 | 48 | 1.01 |
| HIV-RNA, copies/mL | |||
| Missing* | 46 558 | 44 | 0.95 |
| < 500 | 141 219 | 81 | 0.57 |
| 500-4999 | 31 322 | 11 | 0.35 |
| 5000-49 999 | 41 450 | 25 | 0.60 |
| ≥ 50 000 | 26 257 | 26 | 0.99 |
| Duration of cART treatment, mo | |||
| No cART and year < 1996 | 35 477 | 28 | 0.79 |
| No cART and year ≥ 1996 | 73 740 | 43 | 0.58 |
| ≤1 | 2986 | 6 | 2.01 |
| 2 | 2932 | 2 | 0.68 |
| 3 | 2976 | 7 | 2.35 |
| 4-6 | 8499 | 8 | 0.94 |
| > 6 | 160 196 | 93 | 0.58 |
| . | PY of follow-up . | No. of cases . | Incidence per 1000 PYs . |
|---|---|---|---|
| All | 286 806 | 187 | 0.65 |
| Age, y | |||
| 15-34 | 109 840 | 64 | 0.58 |
| 35-49 | 137 154 | 105 | 0.77 |
| ≥ 50 | 39 813 | 18 | 0.45 |
| Sex and exposure group | |||
| MSM | 96 367 | 90 | 0.93 |
| IDU | 38 678 | 25 | 0.65 |
| Other men | 73 072 | 55 | 0.75 |
| Other women | 78 690 | 17 | 0.22 |
| Migration from sub-Saharan Africa | |||
| No | 250,578 | 177 | 0.71 |
| Yes | 36 229 | 10 | 0.28 |
| Calendar period | |||
| <1996 | 35 477 | 28 | 0.79 |
| 1996-1999 | 59 630 | 36 | 0.60 |
| 2000-2007 | 191 699 | 123 | 0.64 |
| CD4 cell count | |||
| Unknown | 4999 | 8 | 1.60 |
| 0-49 | 11 896 | 16 | 1.34 |
| 50-99 | 8141 | 19 | 2.33 |
| 100-199 | 22 939 | 34 | 1.48 |
| 200-349 | 55 832 | 51 | 0.91 |
| 350-499 | 66 301 | 32 | 0.48 |
| ≥ 500 | 116 698 | 27 | 0.23 |
| AIDS | |||
| No | 239 405 | 139 | 0.58 |
| Yes | 47 401 | 48 | 1.01 |
| HIV-RNA, copies/mL | |||
| Missing* | 46 558 | 44 | 0.95 |
| < 500 | 141 219 | 81 | 0.57 |
| 500-4999 | 31 322 | 11 | 0.35 |
| 5000-49 999 | 41 450 | 25 | 0.60 |
| ≥ 50 000 | 26 257 | 26 | 0.99 |
| Duration of cART treatment, mo | |||
| No cART and year < 1996 | 35 477 | 28 | 0.79 |
| No cART and year ≥ 1996 | 73 740 | 43 | 0.58 |
| ≤1 | 2986 | 6 | 2.01 |
| 2 | 2932 | 2 | 0.68 |
| 3 | 2976 | 7 | 2.35 |
| 4-6 | 8499 | 8 | 0.94 |
| > 6 | 160 196 | 93 | 0.58 |
HIV-RNA measurements have been available since 1997.